Lv4
730 积分 2022-12-04 加入
Particle radiotherapy in the era of radioimmunotherapy
1个月前
已完结
Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study
2个月前
已完结
Efficacy, Safety, Blood Kinetics, and213Bi Distribution Studies of [225Ac]Ac-SibuDAB in Prostate Cancer Patients
2个月前
已完结
Designing nanozymes for in vivo applications
6个月前
已完结
Dual-targeted alpha therapy mitigates prostate cancer and boosts immune checkpoint blockade therapy
6个月前
已完结
An Anti-EGFR Antibody-Drug Radioconjugate Labeled with Actinium-225 Elicits Durable Anti-Tumor Responses in KRAS and BRAF Mutant Colorectal Cancer
6个月前
已完结
Efficacy, Safety, Blood Kinetics, and213Bi Distribution Studies of [225Ac]Ac-SibuDAB in Prostate Cancer Patients
7个月前
已完结
The Future of Follicular Lymphoma Management: Strategies on the Horizon
7个月前
已完结
Building the Future Management of Follicular Lymphoma with T-Cell-Redirecting Strategies
7个月前
已完结
Tumor Targeting of 211At-Labeled Antibody under Sodium Ascorbate Protection against Radiolysis
7个月前
已完结
皖公网安备34019202002308
